The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmaMATCH) Trial: a multiple parallel-cohort, phase IIa platform trial aiming to provide proof of principle efficacy for designated targeted therapies in patient subgroups identified through ctDNA screening (CRUK/15/010)
Kernaghan, S Moretti, L Kilburn, L Wilkinson, K Snowdon, C Morden, J Macpherson, I Wardley, Andrew M Roylance, R Baird, R
Kernaghan, S
Moretti, L
Kilburn, L
Wilkinson, K
Snowdon, C
Morden, J
Macpherson, I
Wardley, Andrew M
Roylance, R
Baird, R
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Kernaghan S, Moretti L, Kilburn L, Wilkinson K, Snowdon C, Morden J, et al. The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmaMATCH) Trial: a multiple parallel-cohort, phase IIa platform trial aiming to provide proof of principle efficacy for designated targeted therapies in patient subgroups identified through ctDNA screening (CRUK/15/010). Trials. 2019;20(Suppl 1)